Webinar: The Future of the Pharma Industry

The UK’s withdrawal from the European Union has meant the pharmaceutical industry has had to adapt to some monumental changes in terms of research, regulatory affairs, and trade. In this CPHI Webinar, three industry experts discussed what the future may hold for UK pharma in a post-Brexit world

This edition of the Journal focuses on adaptability. Martin Lush highlights the importance of training and education to improve your business and John Johnson explains how to manage the risks associated with outsourcing. We take an in-depth look at the growth of biopharma and med tech in Ireland and how NSF supports this. We also cover the FDA’s Sentinel Initiative and its five-year strategic plan as well as the latest changes in the EU MDR.